These data suggest that histone acetylation is a mechanism involved in the NIS expression induced by suppressing the MAP kinase and PI3K/Akt pathways and HDAC in these non-thyroid cancer cells. The gene discussed is SLC5A5; the disease is thyroid gland carcinoma.